NPS+ Psoriasis 2017 (US)
本報告依據100名美國的皮膚科醫生調查的結果，提供乾癬治療藥的領導品牌的8項產品的醫生的使用趨勢和各種見解的比較、分析，支援客戶的忠誠度的NPS (淨推薦值) 指標的改善。
Dermatologists may be happy with psoriasis treatments overall, but they gave dismal satisfaction scores to 2 of the 8 brands we surveyed them about. There is hope, though, as at least one of those brands is poised for a massive market share gain-up to 1000%-if it can win over Detractors.
Find out what's driving your brand's satisfaction score, and what you can do to improve it, in FirstView's NPS+ Psoriasis 2017 (US) .
Building on the respected net promoter score (NPS), the report compares eight major psoriasis drugs with easy-to-use KPIs that highlight ways you can improve brand health. You'll also see how loyal doctors are to your brand, learn which promotional messages resonate best, and get doctors' candid thoughts in a unique "Brand DNA" section.
We surveyed 100 US-based dermatologists chosen from the largest community of validated physicians in the world. The same community that pharma market researchers trust for reliable, fast intelligence.
We conducted the survey between March 2nd and 8th, 2017.
NPS+ Psoriasis 2017 (US) explores key issues affecting brand loyalty for drug manufacturers. You'll learn:
NPS is a customer loyalty metric developed by (and a registered trademark of) Fred Reichheld, Bain & Company, and Satmetrix. It was introduced by Reichheld in his 2003 Harvard Business Review article One Number You Need to Grow.
NPS measures overall brand satisfaction and loyalty by asking one simple question:
"How likely are you to recommend this brand to a colleague?"
Responses - given on a scale of 0 (not at all likely) to 10 (extremely likely)-are used to classify respondents into 3 categories:
The percentage of detractors - the percentage of promoters = NPS.
For example, 25% Promoters, 55% Passives and 20% Detractors give you an NPS of +5.
NPS can range from -100 (everybody is a Detractor) to +100 (everybody is a Promoter). The higher the score the healthier the brand.
NPS+ turns your Net Promoter Score into actionable information by answering key questions about brand loyalty.
Each NPS+ report examines doctors' relationships with the brands used to treat a major disease area-measuring brand loyalty and showing you how it affects your market share. NPS+ also examines "brand DNA", revealing in doctors' own words what brands mean to them.
Instead of one simple metric, NPS+ gives you a detailed picture of brand health that highlights areas for improvement, and helps you see exactly what steps you need to take next.